These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25936304)

  • 1. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden.
    Dittrich-Riediger J; Schatz U; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():45-52. PubMed ID: 25936304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actual situation of lipoprotein apheresis in Saxony in 2013.
    Emmrich U; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():215-25. PubMed ID: 25936329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run.
    Groß E; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():226-32. PubMed ID: 25936330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
    Heigl F; Hettich R; Lotz N; Reeg H; Pflederer T; Osterkorn D; Osterkorn K; Klingel R
    Atheroscler Suppl; 2015 May; 18():154-62. PubMed ID: 25936320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience.
    Sampietro T; Sbrana F; Bigazzi F; Ripoli A; Dal Pino B; Pasanisi EM; Petersen C; Coceani M; Luciani R; Pianelli M
    Atheroscler Suppl; 2015 May; 18():268-72. PubMed ID: 25936336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors inducing cardiovascular events in patients treated by lipoprotein apheresis.
    Taseva K; Fischer S; Passauer J; Weiss N; Bornstein SR; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):45-50. PubMed ID: 23357140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current situation of lipoprotein apheresis in Saxony.
    Julius U; Taseva K; Fischer S; Passauer J; Bornstein SR
    Atheroscler Suppl; 2013 Jan; 14(1):51-5. PubMed ID: 23357141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different lipoprotein apheresis methods on serum protein levels.
    Julius U; Siegert G; Kostka H; Schatz U; Hohenstein B
    Atheroscler Suppl; 2015 May; 18():95-102. PubMed ID: 25936311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F; Grützmacher P; Blume H; Vogt A;
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):44-49. PubMed ID: 28233268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication and implementation of lipidapheresis, rheopheresis, or immunoadsorption (lessons learnt from Germany's largest apheresis center).
    Heigl F; Hettich R; Lotz N; Reeg H; Eder B; Steckholzer-Kroth K; Browatzki M; Harre K; Arendt R
    Atheroscler Suppl; 2009 Dec; 10(5):137-41. PubMed ID: 20129393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First data from the German Lipoprotein Apheresis Registry (GLAR).
    Schettler VJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F; Ramlow W; Blume H;
    Atheroscler Suppl; 2015 May; 18():41-4. PubMed ID: 25936303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern.
    von Dryander M; Fischer S; Passauer J; Müller G; Bornstein SR; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):39-44. PubMed ID: 23357139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental symptoms and quality of life in lipoprotein apheresis patients in comparison to hemodialysis patients, platelet donors and normal population.
    Stasiewski E; Christoph M; Christoph A; Bittner A; Weidner K; Julius U
    Atheroscler Suppl; 2015 May; 18():233-40. PubMed ID: 25936331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein apheresis--more than just cholesterol reduction?
    Neumann CL; Schulz EG; Hagenah GC; Platzer U; Wieland E; Schettler V
    Atheroscler Suppl; 2013 Jan; 14(1):29-32. PubMed ID: 23357137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment.
    Schampera S; Fischer S; Weiss N; Julius U
    Atheroscler Suppl; 2015 May; 18():209-14. PubMed ID: 25936328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of long-term lipid apheresis at a single center.
    Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
    Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorption.
    Julius U; Tselmin S; Fischer S; Passauer J; Bornstein SR
    Atheroscler Suppl; 2009 Dec; 10(5):12-6. PubMed ID: 20129367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insights into the German Lipoprotein Apheresis Registry (GLAR) - Almost 5 years on.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F; Grützmacher P; Blume H;
    Atheroscler Suppl; 2017 Nov; 30():50-55. PubMed ID: 29096861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease--Additional particular aspects of the Pro(a)LiFe multicenter trial.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2015 May; 18():35-40. PubMed ID: 25936302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.